Granulocyte colony-stimulating factor: Key (F)actor or innocent bystander in the development of secondary myeloid malignancy?

被引：37
作者：
Touw, Ivo P.
Bontenbal, Marijke
机构：
[1] Erasmus Univ, Ctr Med, Dept Hematol, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus Univ, Ctr Med, Dept Med Oncol, NL-3000 CA Rotterdam, Netherlands
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2007年 / 99卷 / 03期
关键词：
D O I：
10.1093/jnci/djk057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：183 / 186
页数：4
相关论文
共 32 条
[1]   EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours [J].
Aapro, M. S. ;
Cameron, D. A. ;
Pettengell, R. ;
Bohlius, J. ;
Crawford, J. ;
Ellis, M. ;
Kearney, N. ;
Lyman, G. H. ;
Tjan-Heijnen, V. C. ;
Walewski, J. ;
Weber, D. C. ;
Zielinski, C. .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (15) :2433-2453
[2]  
AVALOS BR, 1990, BLOOD, V75, P851
[3]   Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project [J].
Bennett, Charles L. ;
Evens, Andrew M. ;
Andritsos, Leslie A. ;
Balasubramanian, Lakshmi ;
Mai, Mark ;
Fisher, Matthew J. ;
Kuzel, Timothy M. ;
Angelotta, Cara ;
Mckoy, June M. ;
Vose, Julie M. ;
Bierman, Philip J. ;
Kuter, David J. ;
Trifilio, Steven M. ;
Devine, Steven M. ;
Tallman, Martin S. .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 135 (05) :642-650
[4]   CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN NODE-POSITIVE BREAST-CANCER - THE RESULTS OF 20 YEARS OF FOLLOW-UP [J].
BONADONNA, G ;
VALAGUSSA, P ;
MOLITERNI, A ;
ZAMBETTI, M ;
BRAMBILLA, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) :901-906
[5]   Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741 [J].
Citron, ML ;
Berry, DA ;
Cirrincione, C ;
Hudis, C ;
Winer, EP ;
Gradishar, WJ ;
Davidson, NE ;
Martino, S ;
Livingston, R ;
Ingle, JN ;
Perez, EA ;
Carpenter, J ;
Hurd, D ;
Holland, JF ;
Smith, BL ;
Sartor, CI ;
Leung, EH ;
Abrams, J ;
Schilsky, RL ;
Muss, HB ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1431-1439
[6]   Severe chronic neutropenia: Treatment and follow-up of patients in the severe chronic neutropenia international registry [J].
Dale, DC ;
Cottle, TE ;
Fier, CJ ;
Bolyard, AA ;
Bonilla, MA ;
Boxer, LA ;
Cham, B ;
Freedman, MH ;
Kannourakis, G ;
Kinsey, SE ;
Davis, R ;
Scarlata, D ;
Schwinzer, B ;
Zeidler, C ;
Welte, K .
AMERICAN JOURNAL OF HEMATOLOGY, 2003, 72 (02) :82-93
[7]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[8]  
DOUG F, 1995, NEW ENGL J MED, V333, P487
[9]  
Freedman MH, 2000, BLOOD, V96, P429
[10]   Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis:: results of a long-term survey [J].
Germeshausen, Manuela ;
Ballmaier, Matthias ;
Welte, Karl .
BLOOD, 2007, 109 (01) :93-99
1234